These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
239 related items for PubMed ID: 11147584
41. Ductal carcinoma in situ (DCIS) in the male breast: a morphologic study of 84 cases of pure DCIS and 30 cases of DCIS associated with invasive carcinoma--a preliminary report. Hittmair AP, Lininger RA, Tavassoli FA. Cancer; 1998 Nov 15; 83(10):2139-49. PubMed ID: 9827718 [Abstract] [Full Text] [Related]
42. Detection of amplified int-2/FGF-3 gene in primary breast carcinomas using differential polymerase chain reaction. Naidu R, Wahab NA, Yadav M, Kutty MK, Nair S. Int J Mol Med; 2001 Aug 15; 8(2):193-8. PubMed ID: 11445874 [Abstract] [Full Text] [Related]
43. Correlation of hormone receptors with Her-2 Neu protein expression and the histological grade in invasive breast cancers in a cohort of Saudi Arabia. Arafah M. Turk Patoloji Derg; 2012 Aug 15; 28(1):38-43. PubMed ID: 22207430 [Abstract] [Full Text] [Related]
44. Pattern of gene alterations in intraductal breast neoplasms associated with histological type and grade. Tsuda H, Fukutomi T, Hirohashi S. Clin Cancer Res; 1995 Mar 15; 1(3):261-7. PubMed ID: 9815981 [Abstract] [Full Text] [Related]
52. The argyrophilic nucleolar organizer regions in ductal carcinoma in situ of the breast. The significance of ploidy and proliferative activity analysis using this silver staining technique. Mourad WA, Setrakian S, Hales ML, Abdulla M, Trucco G. Cancer; 1994 Sep 15; 74(6):1739-45. PubMed ID: 8082076 [Abstract] [Full Text] [Related]
53. Her-2/neu Oncogene Amplification by Fluorescence In Situ Hybridization and Protein Overexpression on Immunohistochemistry in Breast Cancer. Lateef F, Jamal S, Nasir S. J Coll Physicians Surg Pak; 2018 Aug 15; 28(8):581-585. PubMed ID: 30060783 [Abstract] [Full Text] [Related]
54. Expression of cytokeratin markers, ER-alpha, PR, HER-2/neu, and EGFR in pure ductal carcinoma in situ (DCIS) and DCIS with co-existing invasive ductal carcinoma (IDC) of the breast. Steinman S, Wang J, Bourne P, Yang Q, Tang P. Ann Clin Lab Sci; 2007 Aug 15; 37(2):127-34. PubMed ID: 17522367 [Abstract] [Full Text] [Related]
55. Ductal carcinoma in situ and the emergence of diversity during breast cancer evolution. Allred DC, Wu Y, Mao S, Nagtegaal ID, Lee S, Perou CM, Mohsin SK, O'Connell P, Tsimelzon A, Medina D. Clin Cancer Res; 2008 Jan 15; 14(2):370-8. PubMed ID: 18223211 [Abstract] [Full Text] [Related]
56. Chromosome 1 aneusomy, identified by interphase cytogenetics, in mammographically detected ductal carcinoma in situ of the breast. Harrison M, Magee HM, O'Loughlin J, Gorey TF, Dervan PA. J Pathol; 1995 Mar 15; 175(3):303-9. PubMed ID: 7745499 [Abstract] [Full Text] [Related]
57. Amplification of growth regulatory genes in intraductal breast cancer is associated with higher nuclear grade but not with the progression to invasiveness. Glöckner S, Lehmann U, Wilke N, Kleeberger W, Länger F, Kreipe H. Lab Invest; 2001 Apr 15; 81(4):565-71. PubMed ID: 11304576 [Abstract] [Full Text] [Related]
58. Widespread chromosomal abnormalities in high-grade ductal carcinoma in situ of the breast. Comparative genomic hybridization study of pure high-grade DCIS. Moore E, Magee H, Coyne J, Gorey T, Dervan PA. J Pathol; 1999 Mar 15; 187(4):403-9. PubMed ID: 10398098 [Abstract] [Full Text] [Related]
60. Ductal carcinoma in situ of the breast: histological classification and genetic alterations. van de Vijver MJ. Recent Results Cancer Res; 1998 Mar 15; 152():123-34. PubMed ID: 9928552 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]